Four things we learnt about the jab campaign from vaccine taskforce boss
Clive Dix says speedy rollout will not slow down due to supply shortages
The head of the vaccine taskforce has bolstered optimism over the UK’s jab campaign by saying that every adult in the country could receive both vaccinations by August.
Speaking to Sky News, Clive Dix, who leads the body that identifies and buys vaccines on behalf of the government, said he was confident in the supply of vaccines due to the “portfolio approach” it took to securing Covid jabs.
The UK has secured access to seven different vaccines, with latest Oxford University tracking showing that it has so far administered 16.12 million doses.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
1. Over by August
Dix told Sky News that every adult in the UK could receive both doses of a Covid vaccine by August “or maybe sooner if we need to”. He said that he is “confident... that the supply we’re going to get will take to us to a position where we can vaccinate as many people as the UK wants to vaccinate”.
2. Supply will not slow
Having made such a fast start, the question on everybody’s lips is whether “supply issues will cause a fall in the vaccination rate over the next few weeks”, says Politico’s London Playbook.
But Dix moved to allay these fears, saying: “Of course they could have a manufacturing problem, like you do with any manufacture of anything but with vaccines being more complicated, you could have a problem. But because we’ve taken a portfolio approach we’ve got other vaccines that are going to be approved in the very near future.”
3. Tweaking vaccines
The interview also saw Dix “reveal that new vaccines could be approved in just six to eight weeks in the event new variants are discovered, rather than the year it took to get the first vaccines”, Sky News says.
He said that a tweaked vaccine could take “40 days to have it tested in the clinic and know it works”, adding: “Then manufacture would take another period of time because you wouldn’t manufacture huge amounts before you know it works. So it is a short period of time, it’s not waiting a year like we did this time.”
How vaccines can be ‘tweaked’ to combat new Covid variants
4. Early data is promising
The taskforce boss said all the early data suggests the vaccines are as effective as the government hoped.
“It’s looking like these vaccines are doing exactly what we expect,” he said. “Infection rates are going down, hospitalisations are going down and people are remaining - I wouldn’t say virus-free, because we don’t know that - but we know that they’re not getting serious disease. That’s what we were trying to do.”
How many people need to be vaccinated to get life back to normal?
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Why are people microdosing Ozempic?
In The Spotlight Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a good idea?
By Chas Newkey-Burden, The Week UK Published
-
Five festive cocktails for Christmas 2024
The Week Recommends Serve seasonal libations for an extra special gathering
By Adrienne Wyper, The Week UK Published
-
Octopuses could be the next big species after humans
UNDER THE RADAR What has eight arms, a beaked mouth, and is poised to take over the planet when we're all gone?
By Rafi Schwartz, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published